kV-*»'

ESPGHAN/ /
56th Annual Meeting
of the European Society for
Paediatric Gastroenterology,
Hepatology and Nutrition

15-18 May 2024 | Milan, Ita ly

www.espghancongress.org

Abstracts
E-Book

http://www.espghancongress.org


'ESPGHAN
15-18 May 2024 | M ilan, Ita ly

56th Annual Meeting of the European
Society For Paediatric Gastroenterology,
Hepatology and Nutrition

Table of Contents

ORAL PRESENTATIONS...............................02
POSTER WALK ON BOARDS.......................285
E-POSTER PRESENTATIONS...................... 419
POSTERS ON BOARDS................................ 559
E-POSTER VIEWING..................................... 1208
ENDOSCOPY VIDEO E-POSTERS............... 1684

AUTHOR INDEX............................................1699



FESPGHAN
H-071

15-18 May 2024 | M ilan, Ita ly

56th Annual Meeting of the European
Society For Paediatric Gastroenterology,
Hepatology and Nutrition

Topic: AS02. HEPATOLOGY/ AS02a. General Hepatology

Posters Onsite on Boards
POSTER VIEWING ON BOARDS: HEPATOLOGY - AS02A. GENERAL HEPATOLOGY 
15-05-2024 08:00 - 19:00

BIOCHEMICAL INDICATORS OF LIVER FIBROGENESISIN CHILDREN WITH OBESITY

Larysa Strashok1, Olena Buznytska2, Elina Zavelya1, Margaryta Khomenko3
1Pediatrics, Kharkiv National Medical University, 1SI «Institute for Children and Adolescents Health Care of the NAMS 
of Ukraine», Ukraine, Kharkiv, Ukraine, 2Pediatrics, V.N. Karazin Kharkiv National University, 1SI «Institute for Children 
and Adolescents Health Care of the NAMS of Ukraine», Ukraine, Kharkiv, Ukraine, 3Pediatrics, V.N. Karazin Kharkiv 
National University, Kharkiv, Ukraine

Objectives and Study: To improve the effectiveness of noninvasive diagnosis of liver fibrosis in children with obesity 
using serum biomarkers of liver fibrogenesis.

Methods: On the base of SI “Institute for Children and Adolescents Health Care of the NAMS of Ukraine”, Kharkiv, 
were inspected 226 patients with obesity in age 8-18 years and 30 healthy children for control group. Investigation of 
liver fibrogenesis consisted of measurement in blood serum of level Fibronectin (70±14.0 mkg/ml), serum collagen type 
IV (99±2.3 mkg/l). Statistical processing was made by program Statistics.

Results: It was found that 113 (50.0 ± 3.33%) patients had insulin resistance (IR) according the level of the HOMA-IR 
index. The study of liver fibrogenesis revealed a significant increase in levels of type IV collagen and fibronectin in 
children with obesity (p< 0.05), (Table 1).The levels of Fibronectin significantly differed in groups, depending on the 
presence of IR, which apparently indicates a more severe liver damage in children with IR (p < 0.05). Table 1.Levels of 
collagen type IV and fibronectin (M ± a)

Children with obesity n Collagen type IV, mkg/l Fibronectin, mkg/ml
IR + 113 107.61 ± 7.04* 115.86 ± 7.20* **
IR - 113 103.76 ± 8.31* 93.00 ± 6.31*
Controlgroup 30 85.91 ± 2.38 78.36 ± 2.12

* Difference between patients with obesity and healthy children (p < 0.05) ** Difference between patients 
with IR and without it (p < 0.05)

Conclusions: Thus, non-invasive diagnostic methods using serum biomarkers (type IV collagen, Fibronectin) have 
confirmed their diagnostic significance in establishing of liver fibrogenesis on the early stages formation in children with 
obesity.

Contact e-mail address: laspediatr1984@gmail.com

mailto:laspediatr1984@gmail.com


56th Annual M eeting o f the European
‘ r==> "» I I  A K  1 Society for Paediatric Gastroenterology, 

j  |  | | | ^  Hepatology and N utrition

^  15-18 Mav 2024 1 Milan. Ita lv
S to lo v a s ,A ie le t - G -O 015

S to ltz  S jo s tro m ,E lisa b e th  - N -O 0 1 5

S to p k a ,W ik to r  - H -O 0 2 7

S to rd a l,K e til - G -2 8 0 , G -O 0 0 5 , G -O 0 0 8 , G -O 0 6 7 , G -O 0 7 7 , G -O 0 9 0

St0rd a l,K e til - E P P 0 4 5 , N -1 3 0

S to rm o n ,M ich ae l - E P P 0 2 5 , H -O 0 1 0

S t P e te r ,S h a w n  D . - G -3 1 6

S tra c u z z i,M a rta  - H -O 0 2 5

S tra in ,Ja m ie  - H -O 0 2 3

S tran ak ,Z b y n ek  - E P V 3 2 2

S tra sh o k ,L a ry sa  - H -0 7 1 , H -0 7 2 , H -073

S tra tto n ,M ich a e l R . - G -3 1 7

S tra tto n ,R e b e c c a  J  - E P P 0 1 0 , N -0 4 0 , N -041

S trick e r,S eb as tian  - E P V 0 6 4 , G -0 0 1 , G -O 0 1 2 , I-005

S tr isc iu g lio ,C a te rin a  - E P P 0 5 3 , E P P 0 6 4 , E P P 0 6 8 , G -0 8 2 , G -0 8 3 , G -0 9 5 , G -1 6 7 , G -1 8 5 , G -1 9 2 , G -2 0 2 , 
N -0 7 0

S tro p p a ,P a o la  - H -101

S tru y s ,E d u a rd  A . - E P P 055

S tu d y  G ro u p ,C e d a ta  - G -2 1 3 , G -O 055

S tu d y  G ro u p ,Im p e n sa  - I-O 005

S tü k e r,D ie tm a r - H -0 0 7

S tu rm ,E k k eh a rd  - H -0 0 7 , H -0 4 8 , H -0 6 4 , H -O 0 0 9 , H -O 0 2 2 , H -O 0 2 6 , H -O 0 3 1 , H -O 0 3 7 , N -O 0 2 8

S tu tts ,Jo h n  T . - E P V 291

S u a re z ,M a rg a r ita  - E P V 2 5 1 , E P V 2 5 2

S u arez  T ra b a ,O lg a  M a r ia  - E P V 172

S u c h ism ita ,A ry a  - H -O 0 0 3 , H -O 0 1 8

S u d arm o ,S u b ijan to  M . - G -163

S u k arja ,D is ty ay u  - N -0 8 9 , N -0 9 0

S u m e r C o sa r,O z lem  - E P V 1 0 7 , E P V 1 3 7 , E P V 1 5 8 , H -0 7 4

S u m itro ,K h ad ijah  R. - G -163

S u n d a ra m ,S h ik h a  S. - E P P 0 2 5 , H -O 0 1 0

S u n ,G u iju  - E P V 3 3 0

S u n ,L in a  - E P P 0 7 4 , E P V  166, G - 124, G -241

S u n ,T ian  - H -0 4 9

S u p erin a ,R ic ca rd o  - H -O 0 1 9 , H -O 0 4 0

S u p h a p e e tip o rn ,K a n y a  - H -0 6 8

S u p p a p itip o rn ,S ir ilu c k  - E P V 2 9 0

S u ra ta n n o n ,N a rissa ra  - G -3 0 2

S u ri,V an i - G -0 9 9

S ü rm eli O n a y ,O z g e  - N -O 0 1 4



56th Annual M eeting o f the European
‘ r==> "» I I  A K  1 Society for Paediatric Gastroenterology, 

j  |  | | | ^  Hepatology and N utrition

^  15-18 Mav 2024 1 Milan. Ita lv
Z ara te  M o n d ra g 6 n ,F lo ra  E. - E P V 225

Z a ru b o v a ,K ris ty n a  - G -2 1 4 , N -0 7 2

Z a v e ly a ,E lin a  - H -0 7 1 , H -0 7 2

Z a v h o ro d n ia ,N a ta lia  - H -0 8 7 , H -0 8 8

Z a w o rsk i,K a m il - G -O 0 1 7

Z d a n o w ic z ,K a ta rz y n a  - E P V 0 9 1 , E P V 1 5 6 , E P V 1 9 2

Z d u n -R y z e w sk a ,A g a ta  - G -128

Z e c c o lin i,M a ss im o  - G -1 3 4

Z e e v e n h o o v e n ,Ju d ith  - G -1 5 6

Z e llo s ,A g la ia  - E P P 0 2 5 , E P P 0 6 8 , E P V 2 7 5 , G -O 0 8 7 , H -O 0 1 0

Z e m h e ri,I t ir  E b ru  - E P V 197, E P V 198

Z en g ,Z h e  A . - N -1 3 8 , N -1 5 4

Z e n i,N ic o la  - E P V 2 6 8

Z e n k o v a ,K a rin a  - E P V 3 0 7

Z e p c iu c ,A d e lin a  - G -038

Z e re m ,M a ta n  - G -O 0 3 7

Z e r lo tin ,P a o la  - E P P 0 7 6

Z e tte rs tro m ,C e c ilia  K . - G -2 5 6

Z e tte r s tro m ,R o lf  - G -008

Z e v it,N o a m  - E P P 0 6 4 , G -0 2 9 , G -0 6 4 , G -0 8 5 , G -O 0 2 5

Z h a n g ,B in  - N -0 8 2 , N -1 5 5

Z h a n g ,F a n  - G -O 0 6 2 , N -1 5 6

Z h a n g ,J in p in g  - E P V 3 2 6 , N -0 2 6 , N -0 6 1 , N -O 0 3 3

Z h a n g ,L e  - E P V 0 6 0

Z h a n g ,M a o lin  - N -O 0 2 7

Z h a n g ,T in g  - E P P 0 7 3 , G -1 5 7 , G -2 1 1 , G -2 1 2 , N -0 2 3 , N -0 2 5 , N -1 1 2

Z h a n g ,X in  - E P P 0 5 9 , G -O 0 7 0 , G -O 0 7 9

Z h a n g ,Y a n  - N -1 4 5 , N -1 5 7 , N -O 0 3 2

Z h ao ,H o n g m e i - E P P 0 1 4

Z h ao ,X ia n fe n g  - N -0 7 5 , N -081

Z h a o ,Y u lin g  - G -O 0 2 4 , N -O 0 2 9

Z h e ly a z k o v a ,D e s is lv a  - N -1 1 6

Z h e n g ,H e n g q i B e tty  - G -0 9 2

Z h e n g ,Y u h u a  - G -O 0 1 6

Z h en g ,Y u x in g  - N -0 8 2

Z h o n g ,W a n y in g  - N -1 3 8 , N -1 5 4

Z h o u ,J ie  - G -O 023

Z h o u ,J in  - E P V 3 3 0

Z h o u ,Y o n g c h a n g  - H -O 011

Z h u a n g ,W e ih o n g  - N -1 0 5